Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
MLTX compared with OCUL: revenue, margins and what each company keeps, and the suppliers and customers both name
MLTX
MoonLake Immunotherapeutics
Change
Mkt cap
Revenue
Revenue
OCUL
Ocular Therapeutix, Inc
Change
Mkt cap
Revenue
Revenue
vs
Compare
MLTX
MoonLake Immunotherapeutics
vs
OCUL
Ocular Therapeutix, Inc
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Revenue flow
Desk
News
Calendar
Saved
Search
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Price
Supply-chain overlap
Revenue flow
MLTX: latest quarter not drawable. OCUL: latest quarter is a loss; flow not drawable.
Method
›
Supply-chain overlap
direct ties · both sides
Sources
›
direct ties · both sides
Only MLTX
1
—
Merck Healthcare KGaA, Darmstadt, Germany
unlisted
supplier
Shared
0
No shared counterparties.
Only OCUL
7
—
Incept
unlisted
supplier
—
Ambulatory surgery centers
unlisted
customer
—
Hospital outpatient departments
unlisted
customer
Role chip = supplier or customer
—
= no ticker (unlisted)
Source: SEC EDGAR
—
Physicians' offices
unlisted
customer
3 more · OCUL chain
›
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
MLTX, solid
OCUL, dashed
MLTX
MoonLake Immunotherapeutics
Change
11.78
▼
−6.28%
· post 11.78
Mkt cap
$1.0B
Revenue
—
Revenue
—
OCUL
Ocular Therapeutix, Inc
Change
6.98
▼
−4.54%
· post 6.98
Closed
Oct 30 '26
Mkt cap
$1.5B
Revenue
$13M
Q2 FY26
Revenue
$52M
FY25
vs
Compare
Closed
Oct 30 '26
MLTX
MoonLake Immunotherapeutics
vs
OCUL
Ocular Therapeutix, Inc
11.78
▼
−6.28%
post 11.78
Price
6.98
▼
−4.54%
post 6.98
$1.0B
Mkt cap
$1.5B
—
Revenue
$13M
Q2 FY26
—
Revenue
$52M
FY25
Change
Change
MLTX
11.78
▼
−6.28%
vs
OCUL
6.98
▼
−4.54%
Closed
Oct 30 '26